Otorhinolaryngological manifestations and delayed diagnosis in Kawasaki disease

M. Rouault1,2, A. Coudert1,2, R. Hermann3,2, Y. Gillet4, E. Truy1,3,2,5, S. Ayari-Khalfallah1,3
1Service d’ORL Pédiatrique, Hôpital Femme Mère Enfants, Centre Hospitalier et Universitaire, Lyon, France
2Université de Lyon, Lyon, France
3Service d’ORL, Hôpital Edouard Herriot, Centre Hospitalier et Universitaire, Lyon, France
4Service d'urgences Pédiatriques, Hôpital Femme Mère Enfants, Centre Hospitalier et Universitaire, Lyon, France
5INSERM U1028, CNRS UMR5292, Lyon Neuroscience Research Center, ImpAct Team, Lyon, France

Tài liệu tham khảo

Nakamura, 2012, Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey, J. Epidemiol., 22, 216, 10.2188/jea.JE20110126 Holman, 2003, Kawasaki syndrome hospitalizations in the United States, 1997 and 2000, Pediatrics, 112, 495, 10.1542/peds.112.3.495 Burns, 2004, Kawasaki syndrome, Lancet Lond Engl, 364, 533, 10.1016/S0140-6736(04)16814-1 Matsubara, 2005, Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease, Clin. Exp. Immunol., 141, 381, 10.1111/j.1365-2249.2005.02821.x Rowley, 2011, Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease, J. Infect. Dis., 203, 1021, 10.1093/infdis/jiq136 Franco, 2010, Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease, Autoimmunity, 43, 317, 10.3109/08916930903405891 Franco, 2014, Specificity of regulatory T cells that modulate vascular inflammation, Autoimmunity, 47, 95, 10.3109/08916934.2013.860524 Newburger, 2004, Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association, Circulation, 110, 2747, 10.1161/01.CIR.0000145143.19711.78 Hsieh, 2002, Clinical features of atypical Kawasaki disease, J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi, 35, 57 Burns, 1991, Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United states multicenter Kawasaki disease study group, J. Pediatr., 118, 680, 10.1016/S0022-3476(05)80026-5 Kryzer, 1992, Kawasaki disease: five-year experience at children's national medical center, Int. J. Pediatr. Otorhinolaryngol., 23, 211, 10.1016/0165-5876(92)90102-U Yoskovitch, 2000, Head and neck manifestations of Kawasaki disease, Int. J. Pediatr. Otorhinolaryngol., 52, 123, 10.1016/S0165-5876(99)00300-6 Sung, 2006, Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease, Pediatr. Infect. Dis. J., 25, 521, 10.1097/01.inf.0000215263.96289.1c Juan, 2007, The clinical manifestations and risk factors of a delayed diagnosis of Kawasaki disease, J Chin Med Assoc JCMA, 70, 374, 10.1016/S1726-4901(08)70023-6 Rooks, 1999, Kawasaki disease presenting as a retropharyngeal phlegmon, Pediatr. Radiol., 29, 875, 10.1007/s002470050717 Hung, 2007, Kawasaki disease resembling a retropharyngeal abscess--case report and literature review, Int. J. Cardiol., 115, e94, 10.1016/j.ijcard.2006.08.095 Kritsaneepaiboon, 2012, Atypical presentation of Kawasaki disease in young infants mimicking a retropharyngeal abscess, Emerg. Radiol., 19, 159, 10.1007/s10140-011-1005-0 Kim, 2016, Atypical Kawasaki disease presenting as a retropharyngeal abscess, Braz J Otorhinolaryngol, 82, 484, 10.1016/j.bjorl.2015.04.014 Furusho, 1984, High-dose intravenous gammaglobulin for Kawasaki disease, Lancet Lond Engl, 2, 1055, 10.1016/S0140-6736(84)91504-6 Newburger, 1986, The treatment of Kawasaki syndrome with intravenous gamma globulin, N. Engl. J. Med., 315, 341, 10.1056/NEJM198608073150601 Durongpisitkul, 1995, The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment, Pediatrics, 96, 1057, 10.1542/peds.96.6.1057 Terai, 1997, Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose, J. Pediatr., 131, 888, 10.1016/S0022-3476(97)70038-6 Zhang, 1999, Factors related to cardiac sequelae of Kawasaki disease, Eur. J. Pediatr., 158, 694, 10.1007/s004310051181 Choi, 2010, A case of Kawasaki disease with coexistence of a parapharyngeal abscess requiring incision and drainage, Korean J Pediatr, 53, 855, 10.3345/kjp.2010.53.9.855 Nomura, 2014, Comparison of patients with Kawasaki disease with retropharyngeal edema and patients with retropharyngeal abscess, Eur. J. Pediatr., 173, 381, 10.1007/s00431-013-2179-0